K913-0326 Screening compound: 1-(6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-5-methylthieno[2,3-d]pyrimidin-4-yl)-4-phenylpiperazine

K913-0326 Screening compound: 1-(6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-5-methylthieno[2,3-d]pyrimidin-4-yl)-4-phenylpiperazine
K913-0326 Screening compound: 1-(6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-5-methylthieno[2,3-d]pyrimidin-4-yl)-4-phenylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound K913-0326
1-(6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-5-methylthieno[2,3-d]pyrimidin-4-yl)-4-phenylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K913-0326

Molecular Formula

C30H32N6O3S (C30 H32 N6 O3 S)

Compound Name

1-(6-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-5-methylthieno[2,3-d]pyrimidin-4-yl)-4-phenylpiperazine

IUPAC name

1-(6-{4-[(2H-13-benzodioxol-5-yl)methyl]piperazine-1-carbonyl}-5-methylthieno[23-d]pyrimidin-4-yl)-4-phenylpiperazine

SMILES

Cc1c(C(N2CCN(Cc(cc3)cc4c3OCO4)CC2)=O)sc2ncnc(N(CC3)CCN3c3ccccc3)c12

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

556.69

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.779

Distribution Coefficient, logD

4.595

Water Solubility, LogSw

-4.81

Polar Surface Area

65.103

Acid Dissociation Constant (pKa)

22.15

Base Dissociation Constant (pKb)

7.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.70

K913-0326 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with K913-0326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K913-0326?
Check Price and Availability of K913-0326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K913-0326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K913-0326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K913-0326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K913-0326 available by request